Abstract:Objective To explore association of endocellular-specific molecule-1 (ESM-1) levels with depression in Alzheimer’s disease (AD). Methods A total of 26 AD patients with depression, 29 AD patients without depression, and 29 healthy controls were involved in this study. Serum ESM-1 were measured using an enzyme-linked immunosorbent assay kit. The Mini-Mental State Examination-Korean version (MMSE-KC) and the Korean version of the Geriatric Depression Scale-Short Form (SGDS-K) were used to evaluate cognitive function and depressive symptoms, respectively. Results Serum ESM-1 were significantly lowered in AD patients with depression than that in AD patients without depression or healthy controls (P?0.05). Serum ESM-1 were negatively correlated with SGDS-K scores (r?=?-0.254, P?=?0.009) while no obvious association was identified between ESM-1 and MMSE-KC scores (r?=?0.120, P?=?0.378) . Conclusions Endocellular-specific molecule-1 levels might be associated with depression in AD.